SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-071230
Filing Date
2022-11-10
Accepted
2022-11-10 16:32:17
Documents
13
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168314-8k_oramed.htm   iXBRL 8-K 26729
2 PRESS RELEASE DATED NOVEMBER 10, 2022 ea168314ex99-1_oramed.htm EX-99.1 86283
  Complete submission text file 0001213900-22-071230.txt   295579

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ormp-20221110.xsd EX-101.SCH 3221
4 XBRL LABEL FILE ormp-20221110_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ormp-20221110_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea168314-8k_oramed_htm.xml XML 3608
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 221377840
SIC: 2834 Pharmaceutical Preparations